Sort
51,593 grants matching “hepatitis”
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence
$2,126,338T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Hepatitis B Clinical Research Network - Data Coordinating Center
$2,125,406Steven H. Belle · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · DK
A Multi-site Multi-Setting RCT of Integrated HIV Prevention and HCV Care for PWID
$2,124,322Lisa R Metsch · Columbia University Health Sciences · R01 · FY2018 · DA
Thailand HIV/AIDS and Infectious Disease Clinical Trials Unit (THAI CTU)
$2,124,233Khuanchai Supparatpinyo · Chiang Mai University · UM1 · FY2021 · AI
SAN DIEGO AIDS CLINICAL TRIAL UNIT
$2,123,616University Of California San Diego · U01 · FY2004 · AI
Role of G protein-coupled receptors in regulating glucose and energy homeostasis
$2,123,373Jurgen Wess · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Task D01 Woodchuck Animal Model for Testing Hepatitis B Virus (HBV) Therapeutics
$2,122,016 · N01 · FY2010 · AI
HIV Neurobehavioral Research Center
$2,121,128Igor Grant · University Of California, San Diego · P30 · FY2008 · MH
Environmental, Microbial and Mammalian Biomolecular Responses to AhR Ligands
$2,120,146Timothy R Zacharewski · Michigan State University · P42 · FY2025 · ES
Infections, immunity, and inflammation in cancer
$2,118,458Eric A Engels · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Emerging Infections Program
$2,118,106Paul R Cieslak · Public Health Services · U01 · FY2011 · CI
Childhood Liver Disease Research Network Data Coordinating Center
$2,117,585John C Magee · University Of Michigan At Ann Arbor · U01 · FY2017 · DK
Mechanisms of Atherogenesis in Insulin Resistance
$2,116,915Ira A Tabas · Columbia University Health Sciences · P01 · FY2010 · HL
Mechanisms of Atherogenesis in Insulin Resistance
$2,116,915Ira A Tabas · Columbia University Health Sciences · P01 · FY2008 · HL
Mechanisms of Atherogenesis in Insulin Resistance
$2,116,915Ira A Tabas · Columbia University Health Sciences · P01 · FY2011 · HL
Mechanisms of Atherogenesis in Insulin Resistance
$2,116,915Ira A Tabas · Columbia University Health Sciences · P01 · FY2009 · HL
Optimization and testing of anti-methamphetamine antibody therapy to support pivotal clinical trials and commercialization
$2,115,968Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2022 · DA
Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
$2,115,615Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Increasing Access to Hepatitis C Treatment in Opioid Endemic Rural Areas: the Kentucky Viral Hepatitis Treatment (KeY Treat) Study
$2,115,178Jennifer R Havens · University Of Kentucky · R01 · FY2018 · DA
Chicago Clinical Trials Unit
$2,115,008Babafemi O Taiwo · Northwestern University At Chicago · UM1 · FY2020 · AI
Epidemiology and Natural History of Cancer-Associated Viruses
$2,113,654Sam M Mbulaiteye · Division Of Cancer Epidemiology And Genetics · ZIA · FY2020 · CA
Gulf Longitudinal Follow-up (GuLF) Study
$2,112,784Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
VACCINATION AGAINST INTRAPARTUM HIV CLADE C TRANSMISSION
$2,111,611Dana-Farber Cancer Institute · P01 · FY2001 · AI
Broadly Effective HCV Vaccine
$2,111,046Mansun Law · Scripps Research Institute, The · P01 · FY2025 · AI
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
$2,109,490Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI